Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury

Dian J Cao, Gabriele G. Schiattarella, Elisa Villalobos, Nan Jiang, Herman I. May, Tuo Li, Zhijian Chen, Thomas G. Gillette, Joseph A Hill

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. Methods: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. Results: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. Conclusions: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.

Original languageEnglish (US)
Pages (from-to)2613-2634
Number of pages22
JournalCirculation
Volume137
Issue number24
DOIs
StatePublished - Jun 12 2018

Fingerprint

GMP synthase (glutamine-hydrolyzing)
Macrophages
DNA
Wounds and Injuries
Phenotype
Pattern Recognition Receptors
Ventricular Remodeling
Ventricular Function
Nitric Oxide Synthase Type II
Innate Immunity
Nucleic Acids
Interferons
Myocardial Ischemia
Disease Progression
Rupture
Myocardium
Ischemia
Heart Failure
Hemodynamics
Myocardial Infarction

Keywords

  • cGAS
  • DNA
  • macrophages
  • myocardial infarction
  • ventricular remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. / Cao, Dian J; Schiattarella, Gabriele G.; Villalobos, Elisa; Jiang, Nan; May, Herman I.; Li, Tuo; Chen, Zhijian; Gillette, Thomas G.; Hill, Joseph A.

In: Circulation, Vol. 137, No. 24, 12.06.2018, p. 2613-2634.

Research output: Contribution to journalArticle

Cao, Dian J ; Schiattarella, Gabriele G. ; Villalobos, Elisa ; Jiang, Nan ; May, Herman I. ; Li, Tuo ; Chen, Zhijian ; Gillette, Thomas G. ; Hill, Joseph A. / Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. In: Circulation. 2018 ; Vol. 137, No. 24. pp. 2613-2634.
@article{5956466aee18457f92c49816dad5d2bc,
title = "Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury",
abstract = "Background: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. Methods: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. Results: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. Conclusions: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.",
keywords = "cGAS, DNA, macrophages, myocardial infarction, ventricular remodeling",
author = "Cao, {Dian J} and Schiattarella, {Gabriele G.} and Elisa Villalobos and Nan Jiang and May, {Herman I.} and Tuo Li and Zhijian Chen and Gillette, {Thomas G.} and Hill, {Joseph A}",
year = "2018",
month = "6",
day = "12",
doi = "10.1161/CIRCULATIONAHA.117.031046",
language = "English (US)",
volume = "137",
pages = "2613--2634",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury

AU - Cao, Dian J

AU - Schiattarella, Gabriele G.

AU - Villalobos, Elisa

AU - Jiang, Nan

AU - May, Herman I.

AU - Li, Tuo

AU - Chen, Zhijian

AU - Gillette, Thomas G.

AU - Hill, Joseph A

PY - 2018/6/12

Y1 - 2018/6/12

N2 - Background: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. Methods: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. Results: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. Conclusions: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.

AB - Background: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. Methods: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. Results: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. Conclusions: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.

KW - cGAS

KW - DNA

KW - macrophages

KW - myocardial infarction

KW - ventricular remodeling

UR - http://www.scopus.com/inward/record.url?scp=85046750225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046750225&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.031046

DO - 10.1161/CIRCULATIONAHA.117.031046

M3 - Article

C2 - 29437120

AN - SCOPUS:85046750225

VL - 137

SP - 2613

EP - 2634

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 24

ER -